Pricing and reimbursement

Pricing and reimbursement

California's Medicaid pharmacy "carve-out" set to boost state's negotiating power, introduce IRP for drugs

California’s Medicaid pharmacy “carve-out” set to boost state’s negotiating power, introduce IRP for drugs

Click here to access GlobalData’s Market Access and Pricing Services

By Margaret Labban

Germany’s ESG Law: A case study for new pharma pricing model

Germany’s ESG Law: A case study for new pharma pricing model

Click here to access GlobalData’s Market Access and Pricing Services

By Brendan Melck

Reimbursement outcomes for combination therapies in breast cancer

Reimbursement outcomes for combination therapies in breast cancer

Click here to access GlobalData’s Market Access and Pricing Services

By Milena Izmirlieva

Why are pharma prices changing?

Why are pharma prices changing?

Click here to access GlobalData’s Market Access and Pricing Services

By Gustav Ando

Japan’s new CEA-based price adjustments set to maintain pricing pressure on innovative drugs

Japan’s new CEA-based price adjustments set to maintain pricing pressure on innovative drugs

Click here to access GlobalData’s Market Access and Pricing Services

By Sophie Cairns

US drug prices rise over 4% in 2021 reversing multi-year trend of slowed growth

US drug prices rise over 4% in 2021 reversing multi-year trend of slowed growth

Click here to access GlobalData’s Market Access and Pricing Services

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive.

Pharmaceutical Technology Weekly Roundup

A weekly roundup of the latest news and analysis, sent every Friday.

Pharma Technology Focus Magazine

The pharmaceutical industry's most comprehensive news and information delivered every month.

I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy

SUBSCRIBED

Thank you for subscribing to Pharmaceutical Technology